Siga Technologies Inc balance sheet
At the end of fiscal 2025, Siga Technologies Inc had total assets of $219m, total liabilities of $20.6m and shareholders' equity of $199m. It held $155m in cash against $0 of debt: net cash of $155m.
Balance sheet
| Fiscal year | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 29 | 20 | 101 | 65 | 118 | 103 | 99 | 150 | 155 | 155 | 118 |
| Receivables | 3 | 2 | 2 | 4 | 3 | 84 | 45 | 21 | 21 | 3 | 7 |
| Inventory | 26 | 3 | 3 | 10 | 20 | 20 | 39 | 64 | 50 | 49 | 41 |
| Total current assets | 69 | 37 | 121 | 180 | 144 | 209 | 186 | 239 | 231 | 213 | 170 |
| Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total assets | 161 | 145 | 203 | 199 | 150 | 215 | 195 | 254 | 244 | 219 | 176 |
| Accounts payable | 3 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 1 | 1 | 1 |
| Deferred revenue (current) | — | 1 | 4 | 2 | 3 | 4 | 11 | 21 | 10 | 10 | 0 |
| Total current liabilities | 7 | 7 | 11 | 92 | 10 | 30 | 22 | 54 | 25 | 18 | 8 |
| Short-term debt | — | — | 0 | 80 | 0 | — | — | — | — | — | — |
| Long-term debt | 67 | 71 | 76 | — | — | — | — | — | — | — | — |
| Total debt | 67 | 71 | 76 | 80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 448 | 468 | 101 | 101 | 20 | 40 | 25 | 57 | 29 | 21 | 10 |
| Shareholders' equity | −287 | −323 | 103 | 98 | 130 | 174 | 170 | 197 | 216 | 199 | 165 |
| Net debt (negative = net cash) | 38 | 51 | −25 | 15 | −118 | −103 | −99 | −150 | −155 | −155 | −118 |
| Shares outstanding | — | 81m | 81m | 81m | 77m | 74m | 73m | 71m | 71m | 72m | 72m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 12 | 21 | 7 | 6 | 2 | 3 | 5 | 7 |
| Inventory | 62 | 50 | 59 | 36 | 48 | 49 | 56 | 41 |
| Total current assets | 181 | 231 | 234 | 229 | 228 | 213 | 212 | 170 |
| Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total assets | 195 | 244 | 247 | 235 | 232 | 219 | 219 | 176 |
| Accounts payable | 1 | 1 | 1 | 1 | 5 | 1 | 6 | 1 |
| Deferred revenue (current) | 14 | 10 | 10 | 10 | 10 | 10 | 9 | 0 |
| Total current liabilities | 22 | 25 | 28 | 23 | 25 | 18 | 65 | 8 |
| Total liabilities | 26 | 29 | 31 | 26 | 28 | 21 | 68 | 10 |
| Shareholders' equity | 169 | 216 | 216 | 209 | 203 | 199 | 152 | 165 |
| Shares outstanding | 71m | 71m | 71m | 72m | 72m | 72m | 72m | 72m |
Compare with peers
- Tango Therapeutics, Inc. balance sheet
- Gossamer Bio, Inc. balance sheet
- Nektar Therapeutics balance sheet
- Ocular Therapeutix, Inc balance sheet
- Invivyd, Inc. balance sheet
Head to head: SIGA vs TNGXGOSS vs SIGANKTR vs SIGAOCUL vs SIGA
More: Biotechnology stocks compared, Health Care sector, rankings of US companies